Related Experiment Video
Updated: Jul 4, 2026
13:10
Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
Published on: May 15, 2013
Beta2-adrenoceptor polymorphisms predict response to beta2-agonists in children with acute asthma
Andrew C Martin1, Guicheng Zhang, Kristina Rueter
1School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia.
Summary
Single nucleotide polymorphisms in the beta(2)-adrenoceptor gene influence treatment response in children with acute asthma. Specific gene variants, like Gln27Glu, are linked to slower or faster recovery times with beta(2)-agonist therapy.
Area of Science:
- Pharmacogenetics
- Pediatric Pulmonology
- Molecular Biology
Background:
- Asthma is a common respiratory condition in children, often treated with inhaled beta(2)-agonists.
- The beta(2)-adrenoceptor gene plays a crucial role in mediating the effects of these bronchodilators.
- Single nucleotide polymorphisms (SNPs) in this gene may affect treatment efficacy.
Purpose of the Study:
- To investigate the association between beta(2)-adrenoceptor gene polymorphisms and the response to inhaled beta(2)-agonists in children experiencing acute asthma.
- To test the hypothesis that specific polymorphisms (Gly16, Gln27) lead to reduced receptor function and slower clinical response.
Main Methods:
- Recruitment of 148 children diagnosed with acute asthma.
- Genotyping of participants for two key beta(2)-adrenoceptor gene SNPs: beta(2)Arg16Gly and beta(2)Gln27Glu.
- Analysis of the time taken for symptom resolution in relation to different genotypes and dosing intervals of beta(2)-agonists.
Main Results:
- The beta(2)Gln27Glu polymorphism showed a significant association with response time (p=0.02 for 1-hourly dosing).
- Children with the Gln27Gln genotype had the slowest response, while Glu27Glu individuals responded most rapidly.
- Intermediate response times were observed in heterozygote individuals for the Gln27Glu polymorphism.
Conclusions:
- Beta(2)-adrenoceptor gene polymorphisms, particularly at the Gln27Glu locus, significantly impact the effectiveness of beta(2)-agonist treatment in acute pediatric asthma.
- Identifying these genetic variations could enable personalized treatment strategies for children with asthma.
- Genotype-specific treatment pathways hold potential for optimizing acute asthma management in pediatric populations.
Related Concept Videos
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:27Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...